Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04000529
Title Phase Ib Study of TNO155 in Combination With Spartalizumab or Ribociclib in Selected Malignancies
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ESP | DEU | BEL | AUS

Facility Status City State Zip Country Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Novartis Investigative Site Westmead New South Wales 2145 Australia Details
Novartis Investigative Site Bruxelles 1200 Belgium Details
Novartis Investigative Site Chengdu Sichuan 610041 China Details
Novartis Investigative Site Koeln 50937 Germany Details
Novartis Investigative Site Hong Kong Hong Kong Details
Novartis Investigative Site Chuo ku Tokyo 104 0045 Japan Details
Novartis Investigative Site Singapore 119228 Singapore Details
Novartis Investigative Site Barcelona Catalunya 08035 Spain Details
Novartis Investigative Site Valencia Comunidad Valenciana 46010 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field